Special Issue "Emerging Zoonotic Diseases 2023"

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Animal Viruses".

Deadline for manuscript submissions: 30 November 2023 | Viewed by 710

Special Issue Editor

Institut de Génétique Moléculaire de Montpellier, University of Montpellier. Pathogenesis and Control of Chronic and Emerging Infections (PCCEI), 60 Rue de Navacelles, 34394 Montpellier, CEDEX 5, France
Interests: pathogenesis and diagnosis of emerging viruses especially flaviviruses and neurotropic viruses
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Zoonotic diseases account for at least 60% of all infectious diseases and no less than two-thirds of new emerging ones, which underlines the importance of monitoring them as early as possible. They can cause considerable economic losses each year, as recently illustrated by the COVID-19 pandemic. Understanding the nature of the animal-to-human transmission of zoonotic diseases is a fundamental requirement for their effective anticipation and control. The changes in our environment caused mainly by human activity and the evolution of human–animal interactions are and will undoubtedly continue to be responsible for several new health crises. These crises will manifest in particular through an increase in the frequency and intensity of epidemics and epizootics. Therefore, the first two decades of the 21st century have so far been marked by the multiple emergence and re-emergence phenomena of viral diseases. Climate change and changes in ecosystems due to biodiversity loss and modifications in land use pose environmental threats to human and animal health.

In this Special Issue, we invite colleagues to submit their original research articles and scientific reviews to assemble a collection of papers highlighting critical advancements in our understanding of on all aspects of viral infection in emerging zoonotic diseases, including (but not restricted to) cellular, molecular, and immunological aspects of infection, cell–virus interactions, factors responsible for virulence, epidemiology, transmission, vector competence, diagnosis, outbreak investigation, and surveillance programs for emerging viruses.

Prof. Dr. Yannick Simonin
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Viruses is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • emerging viruses
  • zoonoses
  • epidemiology
  • pathogenesis
  • cell–virus interaction
  • surveillance program
  • one health
  • innovative diagnosis

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:


Synthetic Frog-Derived-like Peptides: A New Weapon against Emerging and Potential Zoonotic Viruses
Viruses 2023, 15(9), 1804; https://doi.org/10.3390/v15091804 - 24 Aug 2023
Viewed by 323
Given the emergence of the coronavirus disease 2019 (COVID-19), zoonoses have raised in the spotlight of the scientific community. Animals have a pivotal role not only for this infection, but also for many other recent emerging and re-emerging viral diseases, where they [...] Read more.
Given the emergence of the coronavirus disease 2019 (COVID-19), zoonoses have raised in the spotlight of the scientific community. Animals have a pivotal role not only for this infection, but also for many other recent emerging and re-emerging viral diseases, where they may represent both intermediate hosts and/or vectors for zoonoses diffusion. Today, roughly two-thirds of human infections are derived from animal origins; therefore, the search for new broad-spectrum antiviral molecules is mandatory to prevent, control and eradicate future epidemic outbreaks. Host defense peptides, derived from skin secretions of amphibians, appear as the right alternative to common antimicrobial drugs. They are cationic peptides with an amphipathic nature widely described as antibacterial agents, but less is reported about their antiviral potential. In the present study, we evaluated the activity of five amphibian peptides, namely RV-23, AR-23, Hylin-a1, Deserticolin-1 and Hylaseptin-P1, against a wide panel of enveloped animal viruses. A strong virucidal effect was observed for RV-23, AR-23 and Hylin-a1 against bovine and caprine herpesviruses, canine distemper virus, bovine viral diarrhea virus, and Schmallenberg virus. Our results identified these three peptides as potential antiviral-led candidates with a putative therapeutic effect against several animal viruses. Full article
(This article belongs to the Special Issue Emerging Zoonotic Diseases 2023)
Show Figures

Figure 1

Back to TopTop